BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7373379)

  • 21. Schwann-cell injection of cold-preserved nerve allografts.
    Fox IK; Schwetye KE; Keune JD; Brenner MJ; Yu JW; Hunter DA; Wood PM; Mackinnon SE
    Microsurgery; 2005; 25(6):502-7. PubMed ID: 16142793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BN rats do not reject F344 brain allografts even after systemic sensitization.
    Poltorak M; Freed WJ
    Ann Neurol; 1991 Apr; 29(4):377-88. PubMed ID: 1929209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nerve graft immunogenicity as a factor determining axonal regeneration in the rat.
    Gulati AK; Cole GP
    J Neurosurg; 1990 Jan; 72(1):114-22. PubMed ID: 2294170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of nondepleting anti-CD4 monoclonal antibody (Rib 5/2) plus donor antigen pretreatment in peripheral nerve allotransplantation.
    Doolabh VB; Tung TH; Wayne Flye M; Mackinnon SE
    Microsurgery; 2002; 22(8):329-34. PubMed ID: 12497567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local FK506 drug delivery enhances nerve regeneration through fresh, unprocessed peripheral nerve allografts.
    Zuo KJ; Shafa G; Chan K; Zhang J; Hawkins C; Tajdaran K; Gordon T; Borschel GH
    Exp Neurol; 2021 Jul; 341():113680. PubMed ID: 33675777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safe injection of cultured schwann cells into peripheral nerve allografts.
    Ogden MA; Feng FY; Myckatyn TM; Jensen JN; Grand AG; Wood PW; Hunter DA; MacKinnon SE
    Microsurgery; 2000; 20(7):314-23. PubMed ID: 11119286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended survival and function of peripheral nerve allografts after cessation of long-term cyclosporin administration in rats.
    Frazier J; Yu L; Rhee E; Shaw L; LaRossa D; Rostami A
    J Hand Surg Am; 1993 Jan; 18(1):100-6. PubMed ID: 8423292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response and neurotrophic factor interactions in peripheral nerve transplants.
    Gulati AK
    Acta Haematol; 1998; 99(3):171-4. PubMed ID: 9587399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Observations on the blood and perineurial permeability barriers of surviving nerve allografts in immunodeficient and immunosuppressed rats.
    Zalewski AA; Kadota Y; Azzam NA; Azzam RN
    J Neurosurg; 1993 May; 78(5):794-806. PubMed ID: 8468610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axon regeneration through blood vessel allografts after cyclosporine treatment.
    Gulati AK
    J Neurosurg; 1989 Jan; 70(1):115-20. PubMed ID: 2909670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of class II antigens on peripheral nerve allografts.
    Yu LT; Hickey WF; Silvers WS; LaRossa D; Rostami AM
    Ann N Y Acad Sci; 1988; 540():472-4. PubMed ID: 3207279
    [No Abstract]   [Full Text] [Related]  

  • 32. The long-term fate of neurons in allografts of ganglia in AG-B-compatible normal and immunologically tolerant rats.
    Zalewski AA; Silvers WK
    J Neurobiol; 1977 May; 8(3):207-15. PubMed ID: 874477
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
    Holán V; Hasek M; Chutná J; Holoubková I
    Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascularized allogeneic joint, muscle, and peripheral nerve transplantation.
    Muramatsu K; Doi K; Kawai S
    Clin Orthop Relat Res; 1995 Nov; (320):194-204. PubMed ID: 7586827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bridging small-gap peripheral nerve defects using acellular nerve allograft implanted with autologous bone marrow stromal cells in primates.
    Wang D; Liu XL; Zhu JK; Jiang L; Hu J; Zhang Y; Yang LM; Wang HG; Yi JH
    Brain Res; 2008 Jan; 1188():44-53. PubMed ID: 18061586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological and electrophysiological analysis of the peripheral nerve allografts using an immunosuppressive agent.
    Okajima S; Hojo T; Tamai K; Takai S; Hirasawa Y
    Microsc Res Tech; 2002 Jul; 58(1):52-8. PubMed ID: 12112423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral nerve allograft: an assessment of regeneration across pretreated nerve allografts.
    Mackinnon SE; Hudson AR; Falk RE; Kline D; Hunter D
    Neurosurgery; 1984 Nov; 15(5):690-3. PubMed ID: 6334246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential response of sensory and motor axons in nerve allografts after withdrawal of immunosuppressive therapy.
    Midha R; Nag S; Munro CA; Ang LC
    J Neurosurg; 2001 Jan; 94(1):102-10. PubMed ID: 11147877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regeneration in, and properties of, extracted peripheral nerve allografts and xenografts.
    Kvist M; Sondell M; Kanje M; Dahlin LB
    J Plast Surg Hand Surg; 2011 Jun; 45(3):122-8. PubMed ID: 21682608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.